OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidemiology, Screening, and Prevention of Bladder Cancer
Niyati Lobo, Luca Afferi, Marco Moschini, et al.
European Urology Oncology (2022) Vol. 5, Iss. 6, pp. 628-639
Closed Access | Times Cited: 187
Niyati Lobo, Luca Afferi, Marco Moschini, et al.
European Urology Oncology (2022) Vol. 5, Iss. 6, pp. 628-639
Closed Access | Times Cited: 187
Showing 1-25 of 187 citing articles:
Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 167
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 167
Advances in diagnosis and treatment of bladder cancer
Antonio López-Beltrán, Michael S. Cookson, Brendan J. Guercio, et al.
BMJ (2024), pp. e076743-e076743
Open Access | Times Cited: 139
Antonio López-Beltrán, Michael S. Cookson, Brendan J. Guercio, et al.
BMJ (2024), pp. e076743-e076743
Open Access | Times Cited: 139
Sex differences in the association between composite dietary antioxidant index and hyperlipidemia: Insights from NHANES
Xiaofan Miao, Bixia Li, Zhixian Zhu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316130-e0316130
Open Access | Times Cited: 3
Xiaofan Miao, Bixia Li, Zhixian Zhu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316130-e0316130
Open Access | Times Cited: 3
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer
Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 27, pp. 4406-4415
Closed Access | Times Cited: 33
Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 27, pp. 4406-4415
Closed Access | Times Cited: 33
Immune Checkpoint Inhibitors as a Treatment Option for Bladder Cancer: Current Evidence
Tobechukwu Okobi, Trinitas Oserefuamen Uhomoibhi, Darlington E Akahara, et al.
Cureus (2023)
Open Access | Times Cited: 22
Tobechukwu Okobi, Trinitas Oserefuamen Uhomoibhi, Darlington E Akahara, et al.
Cureus (2023)
Open Access | Times Cited: 22
Research progress of N1-methyladenosine RNA modification in cancer
Yafeng Liu, Shujun Zhang, Xiaohui Gao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Yafeng Liu, Shujun Zhang, Xiaohui Gao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma
Roberto Contieri, Alberto Martini, Laura S. Mertens, et al.
European Urology Focus (2024) Vol. 10, Iss. 4, pp. 662-665
Closed Access | Times Cited: 11
Roberto Contieri, Alberto Martini, Laura S. Mertens, et al.
European Urology Focus (2024) Vol. 10, Iss. 4, pp. 662-665
Closed Access | Times Cited: 11
Mini-Review: Current Bladder Cancer Treatment—The Need for Improvement
Emily Gill, Claire M. Perks
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1557-1557
Open Access | Times Cited: 11
Emily Gill, Claire M. Perks
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1557-1557
Open Access | Times Cited: 11
Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis
Xiangping Feng, Zongxin Zhang, Shuiying Mao
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Xiangping Feng, Zongxin Zhang, Shuiying Mao
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Epigenetic and Immunological Features of Bladder Cancer
I. R. Gilyazova, Kadriia Enikeeva, Guzel Rafikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9854-9854
Open Access | Times Cited: 17
I. R. Gilyazova, Kadriia Enikeeva, Guzel Rafikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9854-9854
Open Access | Times Cited: 17
A HER2‐targeted Antibody‐Drug Conjugate, RC48‐ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer
Xuwei Hong, Xu Chen, Hongjin Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 17
Xuwei Hong, Xu Chen, Hongjin Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 17
Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the intratumor heterogeneity and prognostic model development for bladder cancer
Jie Wang, Zili Zuo, Zongze Yu, et al.
Aging (2023) Vol. 15, Iss. 21, pp. 12104-12119
Open Access | Times Cited: 17
Jie Wang, Zili Zuo, Zongze Yu, et al.
Aging (2023) Vol. 15, Iss. 21, pp. 12104-12119
Open Access | Times Cited: 17
LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer
Junya Arima, Hirofumi Yoshino, Wataru Fukumoto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5955-5955
Open Access | Times Cited: 7
Junya Arima, Hirofumi Yoshino, Wataru Fukumoto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5955-5955
Open Access | Times Cited: 7
TM9SF1 promotes bladder cancer cell growth and infiltration
Wei Long, Shi‐Shuo Wang, Zhi‐Guang Huang, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 2, pp. 302-316
Open Access | Times Cited: 5
Wei Long, Shi‐Shuo Wang, Zhi‐Guang Huang, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 2, pp. 302-316
Open Access | Times Cited: 5
CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion
Chao Wang, Xianxu Yang
International Immunopharmacology (2024) Vol. 131, pp. 111613-111613
Closed Access | Times Cited: 5
Chao Wang, Xianxu Yang
International Immunopharmacology (2024) Vol. 131, pp. 111613-111613
Closed Access | Times Cited: 5
Use of 18F‐fluoro‐2‐deoxy‐d ‐glucose (18F‐FDG) PET /CT for lymph node assessment before radical cystectomy in bladder cancer patients
Mattia Longoni, Pietro Scilipoti, Chiara Re, et al.
BJU International (2024) Vol. 134, Iss. 4, pp. 636-643
Open Access | Times Cited: 5
Mattia Longoni, Pietro Scilipoti, Chiara Re, et al.
BJU International (2024) Vol. 134, Iss. 4, pp. 636-643
Open Access | Times Cited: 5
Urinary DNA Methylation Test for Bladder Cancer Diagnosis
In Gab Jeong, Sung‐Cheol Yun, Hong Koo Ha, et al.
JAMA Oncology (2025)
Closed Access
In Gab Jeong, Sung‐Cheol Yun, Hong Koo Ha, et al.
JAMA Oncology (2025)
Closed Access
De toekomst van de uro-oncologische zorg: minder is meer?
Vera C Rutten, Bart M. F. Penninx, Hans M. Westgeest, et al.
Tijdschrift voor Urologie (2025)
Open Access
Vera C Rutten, Bart M. F. Penninx, Hans M. Westgeest, et al.
Tijdschrift voor Urologie (2025)
Open Access
Exploring the impact of chronotype, chrononutrition and lifestyle on bladder cancer
Zofia Strojny, Edyta Kawka, Marcin Strojny, et al.
International Urology and Nephrology (2025)
Closed Access
Zofia Strojny, Edyta Kawka, Marcin Strojny, et al.
International Urology and Nephrology (2025)
Closed Access
Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer
Brett Wiesen, Pamela S. Hargis, Hunter Flores, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Brett Wiesen, Pamela S. Hargis, Hunter Flores, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer
XinJian Wang, Hang You, Teng Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
XinJian Wang, Hang You, Teng Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
The Role of Long Chain Non Coding RNA Mediated ceRNA Network in Bladder Cancer
红丽 赵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1369-1376
Closed Access
红丽 赵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1369-1376
Closed Access
Prognostic and predictive role of circulating tumor DNA detection in patients with muscle invasive bladder cancer: a systematic review and meta-analysis
Xindong Gao, Wenqiang Qi, Junxian Li, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Xindong Gao, Wenqiang Qi, Junxian Li, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Suzuki coupling reaction catalyzed by biosynthesized of gold nanoparticles in water under ultrasonic conditions and its application for treatment of bladder cancer
Jing Liu, Li Guo
Journal of Organometallic Chemistry (2025), pp. 123597-123597
Closed Access
Jing Liu, Li Guo
Journal of Organometallic Chemistry (2025), pp. 123597-123597
Closed Access
